The identification of vitamin D receptors (VDR) in type II pneumocytes prompted researchers to investigate vitamin D’s role in pulmonary maturation and surfactant proteins and phospholipids production to determine if VDD is a risk factor for RDS and whether its effects can be reversed [65,75,76]. The gene discussed is VDR; the disease is newborn respiratory distress syndrome.